DDubaist

ADX · BURJEEL

Burjeel Holdings

Identity revalidation is due; this dated record is not proof of current listing status · 2026-08-10
Research depth
Review ready · verified figures appear when approved
Sector lens
Healthcare
Reporting context
H1/Q2 2026 reviewed IAS 34 and issuer KPI disclosures

Company overview

Exchange
ADX
Ticker
BURJEEL
ISIN
AEE01119B224
Market identifier code (MIC)
XADS
Stable research ID
ADX-BURJEEL
Industry evidence
Integrated healthcare services
Sector
Healthcare
Instrument type
Listed equity
Research status
Review ready · verified figures appear when approved
Latest financial period
H1/Q2 2026 reviewed IAS 34 and issuer KPI disclosures
Identity evidence checked
2026-08-10
Identity checked
Identity revalidation is due; this dated record is not proof of current listing status
Listing lifecycle
Primary active route confirmedA dated identity record does not prove the current listing state after its verification date.
Issuer participationProfile foundation available

Burjeel Holdings · What the issuer can provide

  • current identity confirmation
Review the issuer partnership standard
Coverage basis

Why this company is in the directory

Coverage follows a reconciled listed-security identity and dated evidence. Inclusion describes research scope only; it is not a ranking, recommendation or claim of complete financial coverage.

Identity reconciliation
Exchange and ticker matched the research registry
Current public research layer
Review ready · verified figures appear when approved
Evidence boundary
Identity record checked: 2026-08-10
No source — no fact

Company evidence map

Open a card to inspect its public evidence. Missing, stale, conflicting or unavailable data is never replaced with an estimate.

Review ready · verified figures appear when approved
Open the Company Brief
Public identity dossier

Verified listing identity

The fields below come from the current public company registry and any human-published issuer profile. Empty issuer-contact fields stay visibly missing until source and publication-rights review are complete.

Official listed name
Burjeel Holdings
Available
Exchange
ADX
Available
MIC
XADS
Available
Ticker
BURJEEL
Available
ISIN
AEE01119B224
Available
Instrument
Listed equity
Available
Sector
Healthcare
Available
Industry
Integrated healthcare services
Available
Identity checked
2026-08-10
Available
Official website
Missing
Missing
Investor relations
Missing
Missing
Registered address
Missing
Missing
Public contacts
Missing
Missing
Latest verified update

Company activity context

Only exact-security, human-published activity that passes every public source-document check can appear here.

No linked update currently passes every public gate.

Open the full chronology
No source — no fact

Public identity passport

Required identity fields are shown individually with their evidence state. A public link is not reuse permission, and a blank is never converted to a guess.

Stale

Sector and industry

Healthcare · Integrated healthcare services

Stale

Listing status

Primary active route confirmed

Missing

Official website

Not available in the public evidence layer

Missing

Investor relations

Not available in the public evidence layer

Missing

Registered address

Not available in the public evidence layer

Missing

Public email

Not available in the public evidence layer

Missing

Public phone

Not available in the public evidence layer

Missing

Business description

Not available in the public evidence layer

How fields are verified

Verified issuer profile

A verified public issuer profile has not been published yet.

Business model

Hospitals, medical centres, pharmacies and specialized complex-care services across the GCC.

Dubaist fundamental review

Burjeel — beds that fill and claims that wait

Author
Lapshin Vadim
Evidence checked

Twenty hospitals, forty-four centres, and where the margin actually sits

Burjeel Holdings runs private healthcare across the UAE, Oman and an early-stage Saudi position. At H1 2026 the network covered 20 hospitals, 44 medical centres, 1,784 beds and 1,801 doctors, handling 3.704 million visits in six months. Outpatient utilisation ran at 73% and bed occupancy at 69%.

Hospitals carry the group. FY2025 revenue by asset type was AED 4.773 billion hospitals, AED 463.982 million medical centres, AED 61.282 million pharmacies and AED 185.672 million other, while segment EBITDA came to AED 1.165 billion, AED 50.305 million, AED 6.860 million and negative AED 133.585 million respectively. Central functions absorb roughly what the smaller formats earn.

The claim cycle sits between revenue and cash

Insurers, not patients, settle most bills, and the balance sheet shows it. FY2025 gross trade receivables were AED 3.123 billion against AED 1.067 billion of expected credit loss; by H1 2026 both had grown, to AED 3.365 billion and AED 1.173 billion. The balances are unsecured.

Two mechanisms are routinely merged and should not be. A disallowed claim reduces recognised revenue as variable consideration; expected credit loss addresses recoverability of what was already booked. Payer concentration, tariffs, denial ratios and collection curves are unpublished, so neither can be normalised from outside the company.

The history was pooled before it was listed

The legal parent was incorporated in January 2020, yet FY2019–FY2021 were retrospectively pooled after a common-control transfer in March 2022. The October 2022 flotation sold existing and new shares together. Read a five-year series and its earlier part describes predecessor economics. A second break follows: Abu Dhabi's Unified Procurement Program moved prescribed medicines from gross product revenue to a fixed service fee in August 2025.

A flagship, a closed venture, a fixed coupon

Burjeel Medical City held FY2025 gross property of AED 1.448 billion and net AED 1.060 billion on land leased to 2074, but its own revenue and cash return are not broken out. In Saudi Arabia the 50% PhysioTherabia joint venture closed every centre during H1 2026 with an AED 14.985 million impairment. Funding shifted in July 2026 with a USD 500 million senior unsecured sukuk priced at 7.0% and due 2031. Ownership stays concentrated: VPS Healthcare Holdings holds 70.0%, and the April 2026 general meeting approved combining the Chairman and Chief Executive roles.

What Burjeel has not put on the record

Staffed rather than licensed beds, facility-level occupancy and cash returns, payer names and denial rates, the Medical City ramp, Saudi unit economics, how capital spending divides between upkeep and expansion, and the exact FY2025 dividend payment date all sit outside public disclosure. Nothing on this page is a price, a multiple or an instruction to trade.

Financial article · plain language

How to read this company's economics

Numerical values remain in the separate source-document check

How the operating model becomes revenue and cash

Healthcare economics run through patient volumes, case or product mix, capacity, payer terms and clinical or manufacturing delivery. Hospitals, pharmacies and drug manufacturing have different recognition and working-capital cycles.

Five questions before reading the headline

1. What created demand?

Separate patient, prescription, product and capacity demand by geography and payer.

2. What was actually delivered?

Tie visits, beds, procedures or units to delivered and billable service.

3. What determines the margin?

Read clinical or product mix, staffing, procurement and utilisation before margin.

4. Where is cash tied up?

Trace insurer receivables, inventory, payables and provisions to cash conversion.

5. What must be funded next?

Match facilities, equipment and manufacturing capex to licensed capacity and demand.

Official-source snapshot

What the company does and where to verify it

A manually reviewed, paraphrased snapshot from issuer and official market records. Each field keeps its exact source and verification date.

No public snapshot has passed this separate review yet.

Official website, investor-relations, market-record and public contact fields remain unavailable here until their exact source, current value and reuse boundary are reviewed. Nothing is inferred from aggregators or another company.

Healthcare provider analytical model

The metrics below define the correct analytical lens for this business model. They contain no company values: a value appears only after official-document provenance and editorial verification.

Licensed and operational beds
Licensed, installed and operational beds kept separate by facility and reporting date.
Bed occupancy
Occupied bed-days relative to available bed-days for the same hospital perimeter and period.
Patient volume
Inpatient admissions, outpatient visits and procedures kept as separate counts.
Revenue per patient
Revenue per visit, admission or procedure with payer, service and period basis stated.
Payer mix
Revenue or patient share by insurer, government, self-pay and other disclosed payer classes.
Read the evidence guide
What changed

Verified company activity

Only exact-security activity that passes the automatic source, locator, date and localization gates is shown. Exceptions remain unpublished. Each date keeps its lifecycle meaning.

Full company chronology

No linked activity currently passes every public source-document check.

Sources

Identity evidence

Identity evidence
Exchange-hosted evidence
Identity record checked
2026-08-10
Evidence host
apigateway.adx.ae
Open the dated sourceReview source and rights policyPublic access to this link is evidence access only. It does not by itself grant automated collection, storage or republication rights.

Research collections

This company appears in the dated public collections below. Membership describes coverage and evidence context; it is not a ranking or recommendation.

ADX companies

Public profiles with canonical exchange ADX.

Membership version
v1
Effective from
Open collection

Healthcare

Public profiles assigned to this sector in the dated public registry.

Membership version
v1
Effective from
Open collection

Full public company reviews

Public profiles with a complete source-linked review currently visible to every reader.

Membership version
v1
Effective from
Open collection

Identity revalidation due

Dated public identity checks earlier than 18 August 2026; this does not assert current listing status.

Membership version
v1
Effective from
Open collection

Public preview

Deep financial analysis

Verified public facts and their source trail remain free. Normalization notes, scenario work and analytical conclusions require an active premium entitlement.

Premium access is not active

Payments are not yet available. No charge can be made.

Dubaist · Free / Premium

Research products

Open this company's free source-linked fundamental-review preview or compare coverage packs and ongoing monitoring. Coverage is not an investment ranking.